Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the...
You must be a Standard 1 Year member to access this content.
Cooley advised Tenable on the deal. Tenable Holdings, Inc. (Nasdaq: TENB) announced that it has signed a definitive agreement to acquire Ermetic Ltd. for a purchase...
You must be a Standard 1 Year member to access this content.
Cooley advised Thirty Madison on the deal. Thirty Madison announced that it will ensure continued care for over a hundred thousand patients after strategically acquiring assets,...
You must be a Standard 1 Year member to access this content.
Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
You must be a Standard 1 Year member to access this content.
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
You must be a Standard 1 Year member to access this content.
Cooley advised Pie Insurance, Kirkland & Ellis advised Centerbridge Partners, and Sullivan & Cromwell advised Allianz X on the deal. Pie Insurance (Pie) executed a $315 million Series...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Cooley advised Movable Ink on the deal. Movable Ink, a leading content personalization provider, announced its definitive agreement to acquire artificial intelligence-powered content engine Coherent Path. Coherent...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Jones Day advised Nurx on the deal while Cooley and Foley & Lardner LLP advised Thirty Madison. Nurx, a female-focused digital healthcare...
You must be a Standard 1 Year member to access this content.
